Israeli ingredients group Gadot Biochemical Industries has acquired an 85% stake in Florida-based US ingredients company Pharmline Holding.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more


Pharmline is a private company that processes and markets ingredients and premixes to the nutraceuticals market in North America. The group posted 2006 revenues of approximately US$37m


“The acquisition of Pharmline is in line with Gadot’s growth strategy — focusing on the nutraceutical and functional food markets,” Jacob Zack, CEO of Gadot, commented. “Pharmline is an important link in the supply chain to these markets and this acquisition will enable Gadot to diversify its products line and to broaden its customer base in North America.”


The deal is expected to be completed by the end of June.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Just Food Excellence Awards - Have you nominated?

Nominations are now open for the prestigious Just Food Excellence Awards - one of the industry's most recognised programmes celebrating innovation, leadership, and impact. This is your chance to showcase your achievements, highlight industry advancements, and gain global recognition. Don't miss the opportunity to be honoured among the best - submit your nomination today!

Nominate Now